You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

CLINICAL TRIALS PROFILE FOR FLUARIX QUADRIVALENT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FLUARIX QUADRIVALENT

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02967393 ↗	Influenza Vaccine Feasibility Study in Children With Persistent Asthma	Completed	Centers for Disease Control and Prevention	Phase 4	2016-10-10	This study is designed to note whether a larger safety study using quadrivalent live attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine (IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients in this study will receive the FLUARIX® influenza vaccine, while the other half will receive a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as a surrogate for LAIV4.
NCT02967393 ↗	Influenza Vaccine Feasibility Study in Children With Persistent Asthma	Completed	Children's Hospital Medical Center, Cincinnati	Phase 4	2016-10-10	This study is designed to note whether a larger safety study using quadrivalent live attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine (IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients in this study will receive the FLUARIX® influenza vaccine, while the other half will receive a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as a surrogate for LAIV4.
NCT02967393 ↗	Influenza Vaccine Feasibility Study in Children With Persistent Asthma	Completed	Duke University	Phase 4	2016-10-10	This study is designed to note whether a larger safety study using quadrivalent live attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine (IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients in this study will receive the FLUARIX® influenza vaccine, while the other half will receive a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as a surrogate for LAIV4.
NCT02967393 ↗	Influenza Vaccine Feasibility Study in Children With Persistent Asthma	Completed	Vanderbilt University	Phase 4	2016-10-10	This study is designed to note whether a larger safety study using quadrivalent live attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine (IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients in this study will receive the FLUARIX® influenza vaccine, while the other half will receive a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as a surrogate for LAIV4.
NCT02967393 ↗	Influenza Vaccine Feasibility Study in Children With Persistent Asthma	Completed	Vanderbilt University Medical Center	Phase 4	2016-10-10	This study is designed to note whether a larger safety study using quadrivalent live attenuated influenza vaccine (LAIV4) versus quadrivalent inactivated influenza vaccine (IIV4)(FLUARIX®), would be feasible in children with persistent asthma. Half of the patients in this study will receive the FLUARIX® influenza vaccine, while the other half will receive a cell cultured quadrivalent inactivated influenza vaccine (ccIIV4)(Flucelvax®) being used as a surrogate for LAIV4.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FLUARIX QUADRIVALENT

Condition Name

Chart
Table

Condition Name for FLUARIX QUADRIVALENT
Intervention	Trials
Asthmatic	1
Influenza Vaccines in Asthma Populations	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FLUARIX QUADRIVALENT
Intervention	Trials
Influenza, Human	1
Asthma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FLUARIX QUADRIVALENT

Trials by Country

Map
Table

Trials by Country for FLUARIX QUADRIVALENT
Location	Trials
United States	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FLUARIX QUADRIVALENT
Location	Trials
Tennessee	1
Ohio	1
North Carolina	1
Georgia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FLUARIX QUADRIVALENT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FLUARIX QUADRIVALENT
Clinical Trial Phase	Trials
Phase 4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FLUARIX QUADRIVALENT
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FLUARIX QUADRIVALENT

Sponsor Name

Chart
Table

Sponsor Name for FLUARIX QUADRIVALENT
Sponsor	Trials
Vanderbilt University	1
Vanderbilt University Medical Center	1
Centers for Disease Control and Prevention	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FLUARIX QUADRIVALENT
Sponsor	Trials
Other	4
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.